Skip to main content
. 2023 Apr 1;13:5335. doi: 10.1038/s41598-023-32274-4

Table 1.

Baseline characteristics of the study population.

Sham (n = 26) CPAP (n = 26) p Value
Age, year 48.8 ± 10.7 49.1 ± 11.4 0.920
Male sex, n (%) 24 (92) 24 (92) 1.000
Height, cm 169.9 ± 7.3 170.9 ± 6.8 0.583
Weight, kg 76.2 ± 12.6 81.7 ± 11.7 0.108
Body mass index, kg/m2 26.2 ± 3.0 27.8 ± 2.8 0.047
Body surface area, m2 1.90 ± 0.18 1.96 ± 0.18 0.234
Systolic BP mmHg 127.8 ± 16.0 126 ± 19.6 0.722
Diastolic BP mmHg 77.3 ± 10.6 75.8 ± 13.7 0.662
Hypertension, n (%) 15 (58) 17 (65) 0.569
Diabetes mellitus, n (%) 1 (4) 4 (15) 0.158
Dyslipidemia, n (%) 2 (7) 8 (31) 0.035
Current smokers, n (%) 6 (23) 10 (39) 0.229
Medications
 Calcium channel blockers, n (%) 8 (31) 10 (39) 0.560
 RAAS blockers, n (%) 8 (31) 9 (35) 0.768
 Beta-blockers, n (%) 4 (15) 4 (15) 1.000
 Diuretics, n (%) 0 (0) 0 (0) 1.000
 Statins, n (%) 2 (7) 8 (31) 0.035
Polysomnographic characteristics
 AHI, events/hour 53.4 ± 20.5 64.2 ± 20.5 0.063
 Mean oxygen saturation, % 94.5 ± 1.6 93.9 ± 1.7 0.238
 T90, % 7.1 ± 7.3 10.5 ± 11.6 0.210
 Average heart rate during sleep, bpm 62.3 ± 6.3 63.3 ± 6.8 0.576
 Oxygen desaturation index, events/hour 40.8 ± 20.5 47.7 ± 19.6 0.239

Values are n (%) or mean ± standard deviation.

CPAP continuous positive airway pressure, AHI apnea/hypopnea index, BP blood pressure, RAAS renin–angiotensin–aldosterone system, T90 percentage of sleep time below 90% oxygen saturation.